Executive Q&A: Robert C. Coborn, CEO, MicroBioLogics, Inc.

Robert C. Coborn has been at the helm of MicroBioLogics, Inc., a producer of lyophilized microorganisms for quality control in clinical and industrial microbiology laboratories, for the last 24 years. Coborn has played a major role in the development and expansion of the company — originally started with only five employees, MicroBioLogics now employs more than 40 employees and conducts business in nearly 100 countries worldwide via a network of 125 distributors. Coborn attended Harding University in Searcy, Arkansas in 1968 as a business administration major.

In this article, we ask Coborn about the biggest challenges facing today's pharmaceutical quality control laboratories, why these laboratories should consider stock microorganisms over in-house preparations, and what the future might hold for the pharmaceutical and bioresearch industries.